New Study Finds Cranberry Compounds Block Cancer

New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study Indicates B Vitamins not Cardioprotective Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Study: Fish Oils Plus Statins Help Protect Heart Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Fish Oil Supplements Prevent Declines in Heart Rate Variability Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Tomato Extract May Help Lower Blood Pressure Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity. Study Indicates That Lyc-O-Mato® Reduces Blood Pressure Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer. ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural ON's Pro Complex® Augmented Protein System Goes Natural Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Trace Minerals Research Releases New and Improved Performance Electrolyte Formula Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3 Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Nutraceutical Reports FY08 End Results Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Lifeway Foods Announces New West Coast Distribution Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. Mannatech Declares Dividend Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008. NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula	First Study to Confirm Cranberry Proanthocyanidins Inhibit Growth of Tumor Cells NORTH DARTMOUTH, Mass., Jan 25, 2006 /PRNewswire via COMTEX/ -- New data shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. That's according to a new study published in this month's issue of The Journal of the Science of Food and Agriculture. The study, led by University of Massachusetts Dartmouth researcher Catherine C. Neto, Ph.D., is one of the first studies to find that the cranberry's anti-cancer activity may come from the unique structure of its PACs. Cranberry's PACs contain a unique A-type structure, while most other fruit contains only the more-common B-type PACs. Researchers prepared PAC-rich fractions from whole cranberry extract and worked with scientists at the University of Wisconsin to characterize their structures. They tested the fractions against eight tumor cell lines and screened for the effect on tumor growth. The fractions inhibited the proliferation of the tumor cell lines without inhibiting the growth of normal embryonic mouse cells. "While previous studies have shown that cranberry extracts inhibit the proliferation of cancer cells, this is the first study to confirm that it's the cranberry PACs that are the active components," said Catherine C. Neto, Ph.D., Associate Professor, Department of Chemistry and Biochemistry at the University of Massachusetts Dartmouth. "This study is a significant step toward helping to establish a body of research that shows cranberry PACs may also work to prevent tumor cell growth in vivo." Cranberry's PACs have a unique "anti-adhesion" mechanism known to protect the body from the harmful E. coli bacteria that cause UTIs. Earlier research shows that it's the A-type PACs in cranberry that are responsible for this anti-adhesion activity while the B-type PACs in other foods show minimal to no activity. Neto's study shows that the cranberry's anti-cancer activity is also due to its A-type PACs. "In light of our findings and previously published studies, cranberries may inhibit the spread of cancer in a variety of ways," said Neto. "Further research is needed to determine the mechanisms associated with each of the cranberry's active phytochemicals." In addition to helping prevent UTIs, other data has suggested that the unique A-type PACs found in cranberry may also prevent the adhesion of bacteria in the stomach and the mouth, with implications for the prevention of stomach ulcers and gum disease.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software